---
title: CDMO Daily News — July 19, 2026
slug: daily-news-2026-07-19-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: July 19 CDMO daily: OXB Expands AAV Manufacturing with Plowshare Therapies Gene Therapy Deal — OXB's Durham AAV facility now anchors commercial-scale gene…
canonical_url: https://cdmo.directory/posts/daily-news-2026-07-19-cdmo
published_at: 2026-07-19T00:01:12.966Z
last_updated: 2026-07-19T00:02:28.729Z
---

### OXB Expands AAV Manufacturing with Plowshare Therapies Gene Therapy Deal
- OXB signed a GMP manufacturing agreement with Plowshare Therapies for AAV process development and commercial-scale production of a rare disease gene therapy.
- Work will be performed at OXB's FDA-approved viral vector facility in Durham, North Carolina, with potential to expand to additional programs as Plowshare's pipeline advances.
- The partnership reinforces OXB's strategic position in its global AAV network following the facility's acquisition in October 2025.

**Operational Impact**

OXB's Durham AAV facility now anchors commercial-scale gene therapy manufacturing for Plowshare, demonstrating post-acquisition capacity utilization and positioning the site as a hub within OXB's expanded US viral vector network.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/oxb-signs-gene-therapy-manufacturing-agreement-with-plowshare-therapies)*

## References

1. [PharmaSource RSS — OXB Expands AAV Manufacturing with Plowshare Therapies Gene Therapy Deal](https://pharmasource.global/content/news/cdmo-news/oxb-signs-gene-therapy-manufacturing-agreement-with-plowshare-therapies)

Source: https://cdmo.directory/posts/daily-news-2026-07-19-cdmo